High Dose Chemotherapy and Autologous Transplant for Breast Cancer

Completed · Phase 2

Conditions studied: Graft vs Host Disease

In brief

To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy

Key facts

Study ID

NCT00186641

Run by

Stanford University

People needed

203

Expected to finish

2008-02-08

Last updated by the study team

2026-06-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stage II, III or IV breast cancer
• chemosensitive
• adequate organ function

You may not qualify if…

• prior transplant,
• life threatening disease
• brain metastases

Where it is running

• Stanford University Cancer Center — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.